Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Pediatric Blood & Cancer
|
September 17, 2021
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study
Kim Klein, H Berna Beverloo, Martin Zimmermann, et al.
American Journal of Hematology
|
February 13, 2008
Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong Kong
Geoffrey T Gibney, Carolien I M Panhuysen, Jason C C So, et al.
Blood
|
March 10, 2011
A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression
John J Farrell, Richard M Sherva, Zhi-Yi Chen, et al.
Plos One
|
August 13, 2013
Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reaction
Suk Hang Cheng, Kin Mang Lau, Chi Kong Li, et al.
British Journal of Haematology
|
June 25, 2025
Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia
Wing-Yan Leung, Tracy Yuen-Han Lee, Yu-Yan Hwang, et al.
Journal of Hematology & Oncology
|
October 31, 2021
HLA alleles associated with asparaginase hypersensitivity in Chinese children
Gilbert T Chua, Jaime S Rosa Duque, Daniel Ka Leung Cheuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group
Romy E van Weelderen, Kim Klein, Christine J Harrison, et al.
Blood Advances
|
April 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia
Romy E van Weelderen, Christine J Harrison, Kim Klein, et al.
Blood Cancer Discovery
|
August 12, 2022
Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine
Han Wang, Kathy Yuen Yee Chan, Chi Keung Cheng, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Pediatric Blood & Cancer
|
September 17, 2021
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study
Kim Klein, H Berna Beverloo, Martin Zimmermann, et al.
American Journal of Hematology
|
February 13, 2008
Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong Kong
Geoffrey T Gibney, Carolien I M Panhuysen, Jason C C So, et al.
Blood
|
March 10, 2011
A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression
John J Farrell, Richard M Sherva, Zhi-Yi Chen, et al.
Plos One
|
August 13, 2013
Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reaction
Suk Hang Cheng, Kin Mang Lau, Chi Kong Li, et al.
British Journal of Haematology
|
June 25, 2025
Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia
Wing-Yan Leung, Tracy Yuen-Han Lee, Yu-Yan Hwang, et al.
Journal of Hematology & Oncology
|
October 31, 2021
HLA alleles associated with asparaginase hypersensitivity in Chinese children
Gilbert T Chua, Jaime S Rosa Duque, Daniel Ka Leung Cheuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group
Romy E van Weelderen, Kim Klein, Christine J Harrison, et al.
Blood Advances
|
April 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia
Romy E van Weelderen, Christine J Harrison, Kim Klein, et al.
Blood Cancer Discovery
|
August 12, 2022
Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine
Han Wang, Kathy Yuen Yee Chan, Chi Keung Cheng, et al.
Page
of 9